Schedule of Individual Financial Statements Condensed Financial Statements [Table Text Block] Auditor's remuneration [abstract] Schedule of Audit Services Schedule Of Auditor Remuneration Table Text Block Tabular disclosure of auditor remuneration. Schedule of All Other Fees Schedule Of Auditor Remuneration All Other Fees Table Text Block Tabular disclosure of auditor remuneration all other fees. Schedule of Consolidated Entity Disclosure Statement Disclosure Of Consolidated Entity Disclosure Statement Table Text Block Schedule disclosing information related to consolidated entity. Rebates percentage Percentage of entity's revenue Aggregate percentage Aggregate Percentage Aggregate percentage. Categories of related parties [axis] Categories of related parties [domain] H.C. Wainwright & Co., LLC [Member] Additional aggregate offering price Ordinary shares, value Issued capital Balance at beginning Balance at ending Issued capital Summary of Material Accounting Policies [Abstract] Range [axis] Range [domain] Bottom of range [Member] Bottom of range [member] Top of range [Member] Top of range [member] Summary of Material Accounting Policies [Line Items] Critical Accounting Estimates and Judgments [Line Items] Number of reportable segments Number Of Reportable Segment Number of reportable segments. Term of vest grand Term Of Vest Grand Term of vest grand. Critical Accounting Estimates and Judgments [Abstract] Critical Accounting Estimates and Judgments [Abstract] Critical Accounting Estimates and Judgments (Details) [Table] Trade and Other Receivables [Axis] Trade And Other Receivables Axis TradeAndOtherReceivablesDomain [Domain] Current [Member] Currents Member Non- current [Member] Non- Current [Member] Non Current Member Revenue and Other Income [Line Items] Summary of Material Accounting Policies (Details) [Table] Other Gains/(Losses) – Net Gains (losses) recognised in other comprehensive income, fair value measurement, assets [abstract] Fair value losses to financial assets Gains (losses) on financial assets at fair value through profit or loss Raw materials Raw materials and stores (Colostrum) Current raw materials Revenue and Other Income [Abstract] Revenue from Operating Activities Revenue and Other Income (Details) [Table] Proceeds from research and development Proceeds From Research Development Proceeds from research and development. Grant Income Other comprehensive income [abstract] Net foreign exchange gains/(losses) Other gains (losses) HJF R&D grant HJFRDGrant HJF R&D grant. Schedule of Income Tax Expense [Abstract] Unused tax losses for which no deferred tax asset has been recognized Unused tax losses for which no deferred tax asset recognised Potential tax benefit @ 25% (2025: 25%) Current tax expense (income) and adjustments for current tax of prior periods Potential tax benefit, percentage Applicable tax rate Share-based payments Tax Effect Of Share Based Payments The amount representing the share-based payments. Net impact of other amounts not deductible (taxable) Tax Effect Of Net Impact Of Other Amounts Not Deductibletaxable Net impact of other amounts not deductible (taxable). Subtotal Tax Effect Of Subtotal Subtotal. Tax losses and other timing differences for which no deferred tax asset is recognized Tax Effect Of Tax Losses And Other Timing Differences For Which No Deferred Tax Asset Is Recognized Tax losses and other timing differences for which no deferred tax asset is recognized. Income tax expense Income tax expense Income tax expense (income), income taxes Project research and development Project Research And Development Represents the amount of project research and development. Research and development expenses, Total Research and development expenses Research and development expenses Research and development expense Subsidiaries [domain] Interests in Other Entities [Line Items] Disclosure of associates [line items] Immuron Limited [Member] Immuron Limited Member Current Trade and other current payables [abstract] Trade payables Current trade payables Accrued expenses Current accrued expenses and other current liabilities Financial Assets and Financial Liabilities [Abstract] Financial Assets and Financial Liabilities (Details) [Table] FVPL [Member] FVPLMember Financial Assets and Financial Liabilities [Line Items] Impairment of the investment Impairment Of The Investment Impairment of the investment. Deposit earning interest rate Deposit Earning Interest Rate Deposit earning interest rate. Non-financial Assets and Liabilities [Abstract] Provision for finished goods Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories Total leave provision Current provisions Interests in Other Entities [Abstract] Categories of financial assets [domain] Maturity Date Maturity date. Total employee benefit obligations Total Employee Benefit Obligations Total employee benefit obligations. Schedule Of Subsidiaries Abstract Other payables Other current payables Current [Member] Current [member] Schedule of Inventories and Employee Benefit Obligations [Line Items] Work in progress Current work in progress Finished goods (Travelan and ProIBS) Current finished goods Interests in Other Entities - Schedule of Subsidiaries (Details) [Table] Subsidiaries [axis] Immuron Inc [Member] Immuron Inc. [Member] Immuron Inc Member Represents the information of Ifrs statement lineItems. Anadis ESP Pty Ltd [Member] Anadis EPSPty Ltd Member Represents the information of anadis ePSPty ltd. Immuron Canada Ltd. [Member] IMCCanada Ltd Member Represents information related to IMC canada ttd. Ateria Health Limited [Member] Ateria Health Limited Member Loss allowance Allowance Account For Credit Losse Of Financial Assets The amount of an allowance account used to record impairments to financial assets due to credit losses. Accrued income – Australian R&D tax incentive refund Accrued income other than contract assets Other receivables Other receivables Total Trade and other receivables Trade and other current receivables Fair value losses to financial assets Fair Value Gainslosses To Financial Assets Fair value gains/(losses) to financial assets. Schedule of Other Current Assets [Abstract] Prepayments Current prepayments Term deposits Short-term deposits, classified as cash equivalents Other current assets Current prepayments and other current assets Total Trade and other payables Trade and other current payables Schedule Of Inventories And Employee Benefit Obligations Abstract Non-Financial Assets and Liabilities - Schedule of Inventories and Employee Benefit Obligations (Details) [Table] Other inventories Other current inventories Total inventories Inventories Share options Share Option Under Fair Value Through Profit Or Loss Represent the number of share option under fair value through profit or loss. Issue at US$1.8939 pursuant to At the Market facility (2025-07-17) Issue of Value at the Market Facility Five Issue of value at the market facility five. Issue at US$1.8782 pursuant to At the Market facility (2025-07-18) (in shares) Issue of Shares Market Facility Six Issue of shares market facility six. Issue at US$1.8782 pursuant to At the Market facility (2025-07-18) Issue of Value at the Market Facility Six Issue of value at the market facility six. Travelan [Member] Travelan Member Protectyn [Member] Protectyn Member Issue at $0.12 on exercise of unlisted options (2024-03-12) Exercise Value of Unlisted Options The amount represents exercise of unlisted options. Titles Of Individual [Axis] Titles Of Individual Axis TitlesOfIndividualDomain [Domain] Mr.Paul Brennan [Member] Mr Paul Brennan Member Mr. Steven Lydeamore [Member] Mr Steven Lydeamore Member Daniel Pollock [Member] Ravi Savarirayan [Member] Shares issued Ordinary shares Balance at beginning (in shares) Balance at ending (in shares) Total number of shares issued Performance rights forfeited (in Dollars) Performance rights forfeited Amount of performance rights forfeited. Performance rights forfeited Number of shares issued of Performance rights forfeited Number of shares of performance rights forfeited. Warrants expired in the year (in Dollars) Amount of warrant expired Amount of warrant expired. Warrants expired in the year Number of warrant expired Number of warrant expired. Share-based payments expense for performance rights previously issued (in Dollars) Share-Based Payments Expense for Performance Rights Previously Issued Share-based payments expense for performance rights previously issued Share-based payments expense for performance rights previously issued Shares of Share-Based Payments Expense for Performance Rights Previously Issued Share-based payments expense for performance rights previously issued. Options expired in the year (in Dollars) Number of Value Issued Options Expired Number of value issued options expired. Options expired in the year Number Of Shares Issued Options Expired Number of shares issued warrants expired. ProIBS [Member] Option life, share options granted Schedule of Financial Information for Associates [Line Items] Share of loss for the period Acquired percentage Percentage of voting equity interests acquired Disclosure of classes of share capital [abstract] Issue of shares on the exercise of performance rights at $0.0 per share (2024-10-07) (in shares) Issue Of Shares On The Exercise Of Performance Rights One Issue of shares on the exercise of performance rights Issue of shares on the exercise of performance rights at $0.0 per share (2024-10-07) Issue Of Value On The Exercise Of Performance Rights One Issue of value on the exercise of performance rights Issue at US$2.1784 pursuant to At The Market facility (2025-01-08) (in shares) Issue Of Shares Market Facility One Issue of shares market facility one Issue at US$2.1784 pursuant to At The Market facility (2025-01-08) Issue Of Value At The Market Facility One Issue of value at the market facility one Issue at US$2.0971 pursuant to At The Market facility (2025-01-15) (in shares) Issue Of Shares Market Facility Two Issue of shares market facility two Issue at US$2.0971 pursuant to At The Market facility (2025-01-15) Issue Of Value At The Market Facility Two Issue of value at the market facility two Issue of shares on the exercise of performance rights at $0.0 per share (2025-04-10) (in shares) Issue Of Shares On The Exercise Of Performance Rights Two Issue of shares on the exercise of performance rights two Issue of shares on the exercise of performance rights at $0.0 per share (2025-04-10) Issue Of Value On The Exercise Of Performance Rights Two Issue of value on the exercise of performance rights two Issue at US$1.8435 pursuant to At The Market facility (2025-05-29) (in shares) Issue Of Shares Market Facility Three Issue of shares market facility three Issue at US$1.8435 pursuant to At The Market facility (2025-05-29) Issue Of Value At The Market Facility Three Issue of value at the market facility three Issue at US$1.8286 pursuant to At The Market facility (2025-06-03) (in shares) Issue Of Shares Market Facility Four Issue of shares market facility four Issue at US$1.8286 pursuant to At The Market facility (2025-06-03) Issue Of Value At The Market Facility Four Issue of value at the market facility four Balance ending Balance beginning Number of shares reserved for issue under options and contracts for sale of shares Balance ending (in Dollars) Balance beginning (in Dollars) Value Reserved For Issue Under Options And Contracts For Sale Of Shares Number of value reserved for issue under options and contracts for sale of shares. Schedule Of Movements In Options Or Warrants And Performance Rights Abstract Disclosure of operating segments [abstract] Disclosure of operating segments [table] Segments [axis] Segments [domain] Research and Development [Member] Segment Research And Development Member Represents the information of segment research and development. Hyper-Immune Products [Member] Segment Hyper Immune Products Member Represents the information of segment hyperImmune products. Movement in inventory provision Movement In Inventory Provision Movement in inventory provision. General and administrative expenses General and administrative expenses General and administrative expenses, Total General and administrative expenses, operating Selling and marketing expenses Selling and marketing expenses Selling and marketing expenses, Total Sales and marketing expense Operating profit/(loss) Operating loss Profit (loss) from operating activities Finance income Finance income Finance costs Finance expenses Finance costs Share of loss from associates Total Share of loss from associates Share of profit (loss) of associates and joint ventures accounted for using equity method, investing Profit/(loss) for the year Loss for the year Profit (loss), attributable to owners of parent Assets Assets [abstract] Segment assets Segment Assets Represents the information of segment assets. Total assets TOTAL ASSETS Assets Geographical areas [domain] Australia [Member] AUSTRALIA Adjustments for Adjustments to reconcile operating profit (loss) [abstract] Share-based payment expenses Share-based payment transactions expense Adjustments for share-based payments Unrealized net foreign currency gains Adjustments for unrealised foreign exchange losses (gains) Change in operating assets and liabilities: Change In Operating Assets And Liabilities Abstract Add decrease / (increase) in trade and other receivables Adjustments for decrease (increase) in trade and other receivables Add decrease / (increase) in inventories Adjustments for decrease (increase) in inventories Canada [Member] CANADA Products and services [axis] Products and services [domain] Components of equity [axis] Share-based payments [Member] Reserve of share-based payments [member] Foreign currency translation [Member] Foreign Currency Translation Member Total other reserves [Member] Reserves Other reserves [member] Schedule of Other Reserves [Line Items] Balance at beginning Balance at ending Other reserves Currency translation differences Increase (decrease) through transactions with owners, equity Types of antidilutive instruments [axis] Warrants [Member] Warrants [member] Schedule of Movements in Options or Warrants and Performance Rights [Line Items] Exercise of unlisted options at $0.12 (2024-03-12) Issue at $0.12 on exercise of unlisted options (2024-03-12) (in shares) Exercise Of Unlisted Options Number of exercise of unlisted options. Options issued in the year (in Dollars) Options/warrants issued/expensed Options Or Warrants Issued Expensed Amount of options or warrants issued. Share-based payments expense for options previously issued Sharebased Payments Expense For Options Previously Issued Share-based payments expense for options previously issued Exercise of performance rights Number Of Shares Issue Exercise Of Performance Rights Exercise of performance rights Exercise of performance rights (in Dollars) Number Of Values Issue Exercise Of Performance Rights Exercise of performance rights Lapse of performance rights issued in the year Number Of Shares Issue Lapse Of Performance Rights Lapse of performance rights issued in the year Lapse of performance rights issued in the year (in Dollars) Performance rights exercised Increase (decrease) through exercise of options, equity Lapse of unexercised options Number Of Shares Issue Lapse Of Unexercised Options Number of shares issued lapse of unexercised options. Issue at US$2.1374 pursuant to At the Market facility (2025-07-21) (in shares) Issue of Shares Market Facility Seven Number of market facility shares. Issue at US$2.1374 pursuant to At the Market facility (2025-07-21) IssueOfValueAtTheMarketFacilitySeven Value of market facility shares. Issue at US$2.3008 pursuant to At the Market facility (2025-10-20) (in shares) Issue Of Shares Market Facility Eight Number of shares issued under market facility. Issue at US$2.3008 pursuant to At the Market facility (2025-10-20) Issue Of Value At The Market Facility Value of shares under market facility. Issue at US$1.9631 pursuant to At the Market facility (2025-11-07) (in shares) Issue Of Shares Market Facility Nine Number of market facility shares issued. Issue at US$1.9631 pursuant to At the Market facility (2025-11-07) Issue Of Value At The Market Facility Nine Value of market facility shares. Issue at US$2.0809 pursuant to At the Market facility (2025-12-05) (in shares) Issue Of Shares Market Facility Ten Number of shares issued under market facility. Issue at US$2.0809 pursuant to At the Market facility (2025-12-05) Issue Of Value At The Market Facility Ten Value of market facility shares. Contingent liabilities or commitments Contingent liabilities Estimated financial effect of contingent liabilities Other Reserves [Abstract] Other Reserves (Details) [Table] Dr. Jeannette Joughin [Member] Dr Jeannette Joughin Member Performance rights, description Performance Rights Description Performance rights description. Estimated fair value Incremental fair value granted, modified share-based payment arrangements Issuing shares (in Dollars) Proceeds from issuing shares Number of reportable segment Number Of Segment It represents as a number of segment. Contingent Liabilities and Commitments [Abstract] Schedule Of Financial Information For Associates Abstract Dr. Jerry Kanellos [Member] Dr Jerry Kanellos Member Mr. Flavio Palumbo [Member] Mr Flavio Palumbo Member Other Reserves [Line Items] Granted option Share Options Share options. Notes and other explanatory information [abstract] Disclosure of terms and conditions of share-based payment arrangement [table] Types of share-based payment arrangements [axis] Types of share-based payment arrangements [domain] Gross carrying amount Gross Carrying Amount Gross carrying amount. Loss allowance Loss On Allowance Trade Receivable Loss Allowance, in the context of IFRS 9, is an estimate linked to expected credit losses on a financial asset that is applied to reduce the carrying amount of the financial asset in the Statement of Financial Position. Schedule Of Contractual Discounted Cash Flows Abstract Disclosure of financial liabilities [table] Maturity [axis] Total contractual cash flows [Member] Contractual Cash Flows Member Schedule of Contractual Discounted Cash Flows [Line Items] Trade and other payables Trade and other payables Lease liabilities Gross lease liabilities Total Financial liabilities Current assets Total Current Assets Current assets Non-current assets Total Non-Current Assets Non-current assets Total assets Other assets Current liabilities Total Current Liabilities Current liabilities Non-current liabilities Total Non-Current Liabilities Non-current liabilities Total liabilities TOTAL LIABILITIES Liabilities Shareholders’ equity EQUITY Equity [abstract] Document Transition Report Document Transition Report Types of antidilutive instruments [domain] Award Dates [Axis] Award Dates Axis Award Dates [Domain] 2019-05-23 (warrants) [Member] Grant Date One Member 2019-07-16 (warrants) [Member] Grant Date Two Member Schedule of Share Options Outstanding [Line Items] Expiry date Share Based Compensation Arrangement By Share Based Payment Award Expiration Date1 Date the equity-based award expires. Exercise price (in Dollars per share) Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise Share options Number of options, Beginning balance Number of options, Ending balance Number of share options outstanding in share-based payment arrangement Weighted average remaining contractual life of options outstanding at end of period Weighted average remaining contractual life of outstanding share options Schedule of Foreign Currency Risk [Line Items] Proceeds from maturity/(payments for) term deposit The amount of proceeds from maturity/(payments for) term deposit. Parent entity financial information Description of accounting policy for impairment of financial assets [text block] Fair value measurement Description of accounting policy for fair value measurement [text block] Schedule of Expenses Disclosure of general and administrative expense [text block] Income Tax Expense [Abstract] Schedule of Income Tax Expense Disclosure Of Unused Tax Losses For Which No Deferred Tax Asset Recognized Text Block Schedule of unused tax losses for which no deferred tax asset recognized. Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable Disclosure Of Income Tax Expense Key Management Personnel Compensation [Abstract] Disclosure of terms and conditions of share-based payment arrangement [abstract] 31-60 [Member] Later than two months and not later than three months [member] 61-90 [Member] Not later than three months [member] 91-120 [Member] Later than three months [member] 121+ [Member] Not later than one year [member] Schedule of Loss Allowance [Line Items] Expected credit loss rate Expected credit loss rate Maturity [domain] Less than 6 months [Member] Later than three months and not later than six months [member] 6 - 12 months [Member] Later than six months and not later than one year [member] Between 1 and 2 years [Member] Later than one year and not later than three years [member] Between 2 and 5 years [Member] Later than one year and not later than five years [member] Over 5 years [Member] Later than five years [member] Schedule of Individual Financial Statements [Abstract] Parent Entity Financial Information Scheduleof Individual Financial Statements [Table] Consolidated Entities [Axis] Parent Company [Member] Parent Company [Member] Parent Entity Financial Information Scheduleof Individual Financial Statements [Line Items] Balance sheet Statement of financial position [abstract] Country of incorporation Country of incorporation Australian resident or foreign resident (for tax purpose) Description Of Resident The description of resident for tax purpose. Cybersecurity Risk Management, Strategy, and Governance [Line Items] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Profit or loss [abstract] Revenue from contracts with customers Revenue from contracts with customers at a point in time Revenue from external customers Revenue from contracts with customers Cost of Goods Sold Cost of sales of goods Cost of sales Gross Profit Gross profit Gross profit Grant Income Total Grant Income Other income Other income Options/warrants lapsed/expired Optionswarrants Lapsedexpiredin Dollars Options warrants lapsed expired. Performance rights issued/expensed Performance Rights Issuedexpensed The amount of performance rights issued expensed. Balance TOTAL EQUITY Total Shareholders' equity Balance Equity Unlisted options issued/expensed Unlisted Options Vested In The Period The amount of unlisted options vested in the period. Options/warrants exercised Options Or Warrants Exercised The increase (decrease) in equity resulting from the exercise of options/warrants. Net Cash Flows Used In Operating Activities Cash flows from (used in) operating activities Cash Flows Related to Investing Activities Cash flows from (used in) investing activities [abstract] Payments for purchases of plant and equipment Purchase of property, plant and equipment, classified as investing activities Interest received Interest received, classified as investing activities Net Cash Flows From/(Used In) Investing Activities Cash flows from (used in) investing activities Cash Flows Related to Financing Activities Cash flows from (used in) financing activities [abstract] Proceeds from issues of securities Proceeds from issuing other equity instruments Share issue transaction costs Payments for share issue costs Entities controlled by key management personnel Amounts payable, related party transactions Schedule of Foreign Currency Risk [Abstract] Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details) [Table] Risk variables [axis] Foreign Currency Risk [Member] Foreign Currency Risk Member Schedule Of Exchange Rates Abstract Disclosure of risks to which entity is exposed when currency is not exchangeable [table] Classes of financial instruments [axis] Classes of financial instruments [domain] Impact on loss for the period [Member] Impact On Loss For The Period Member Impact on other components of equity [Member] Impact On Other Components Of Equity Member Schedule of Exchange Rates [Line Items] Effects of exchange rate changes on cash and cash equivalents Effect of exchange rate changes on cash and cash equivalents Cash and Cash Equivalents at the End of the Year Total Cash and cash equivalents Cash and cash equivalents at the beginning of the year Cash and cash equivalents Expenses Disclosure of expenses by nature [text block] Income Tax Expense Disclosure of income tax [text block] Key Management Personnel Compensation Disclosure of information about key management personnel [text block] Loss per Share [Abstract] Research and development Description of accounting policy for research and development expense [text block] Schedule of Revenue and Other Income Disclosure of other operating income (expense) [text block] Par value per share Total consideration on repurchased and cancelled of shares Repurchased and Cancelled Value of Ordinary Shares Represents the amount of repurchased and cancelled value of ordinary shares. Expenses Expenses [Abstract] Items that may be reclassified to profit or loss: Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract] Exchange differences on translation of foreign operations Other comprehensive income, net of tax, exchange differences on translation of foreign operations Total Comprehensive Loss for the Period Total comprehensive loss for the period Comprehensive income Basic Loss per Share (in cents per share) (in Dollars per share) Basic loss per share (in cents) Basic earnings (loss) per share Diluted Loss per Share (in cents per share) (in Dollars per share) Diluted loss per share (in cents) Diluted earnings (loss) per share Property, plant and equipment Property, plant and equipment Inventories Non-current inventories Current Liabilities Current liabilities [abstract] Employee benefit obligations Current Current provisions for employee benefits NET ASSETS Assets (liabilities) Reserves Capital reserve Accumulated losses Retained earnings Consolidated Statement Of Changes In Equity Abstract Interests in other entities Disclosure of interests in other entities [text block] Company Details [Abstract] Company Details Disclosure Of Company Details Explanatory The disclosure of company details. Contingent liabilities and Commitments Disclosure of commitments and contingent liabilities [text block] Cash Flow Information [Abstract] Cash Flow Information Disclosure of cash flow statement [text block] Share-based Payments Disclosure of share-based payment arrangements [text block] Related Party Transactions [Abstract] Related Party Transactions Disclosure of related party [text block] Document Shell Company Report Document Shell Company Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Emerging Growth Company Entity Emerging Growth Company Entity Filer Category Entity Filer Category ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Average exercise price per share option, Beginning balance Average exercise price per share option, Ending balance Weighted average exercise price of share options outstanding in share-based payment arrangement Average exercise price per share option, Granted during the year Weighted average exercise price of share options granted in share-based payment arrangement Number of options, Granted during the year Number of share options granted in share-based payment arrangement Average exercise price per share option, Exercised during the year Weighted average exercise price of share options exercised in share-based payment arrangement Share capital Disclosure of classes of share capital [text block] Other reserves Disclosure of reserves within equity [text block] Segment Reporting Disclosure of entity's operating segments [text block] Financial Risk Management Objectives and Policies [Abstract] Financial Risk Management Objectives and Policies Disclosure of financial risk management [text block] Events Occurring After the Reporting Date [Abstract] Events occurring after the Reporting Date Disclosure of events after reporting period [text block] Parent Entity Financial Information [Abstract] Segment reporting Description of accounting policy for segment reporting [text block] Foreign currency translation Description of accounting policy for foreign currency translation [text block] Cash and cash equivalents Description of accounting policy for determining components of cash and cash equivalents [text block] Trade receivables Description of accounting policy for trade and other payables [text block] Inventories Description of accounting policy for measuring inventories [text block] Investments and other financial assets Description Of Accounting Policy For Investments Other Financial Assets The description of the entity's accounting policy for investments and other financial assets. Trade and other payables Description of accounting policy for trading income and expense [text block] Employee benefits Description of accounting policy for employee benefits [text block] Mr. Daniel Pollock [Member] Mr Daniel Pollock Member Prof. Ravi Savarirayan [Member] Prof Ravi Savarirayan Member Chief Scientific Officer [Member] Chief Scientific Officer Member Related Party Transactions [Line Items] Schedule of Outstanding Balances Transactions with Related Parties [Line Items] Disclosure of transactions between related parties [line items] Related party transaction Payment To Employee Fund Payment to employee fund. Financial Risk Management Objectives and Policies (Details) [Table] Risk variables [domain] Consolidated Entities [Domain] Debts of subsidiaries Debt instruments issued Acquisition of property, plant or equipment Contractual commitments for acquisition of property, plant and equipment Document Information [Table] Entity Addresses, Address Type [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Performance Rights [Member] Performance Rights Member Related Party Transactions (Details) [Table] Trade Receivables [Member] Trade receivables [member] Financial Risk Management Objectives and Policies [Line Items] Percentage of USD/AUD exchange rate Exchange rate Percentage Of Foreign Exchange Rates Percentage of USD/AUD exchange rate. Trade receivables balance Trade receivables Percentage of trade receivables balances Percentage Of Trade Receivables Balances Percentage of trade receivables balances. Basis of Preparation The description of the entity's material accounting policy information for basis of preparation. Option exercise price Options Exercise Price Per Share Options exercise price per share. Document Accounting Standard Document Accounting Standard Schedule of Outstanding Balances Transactions with Related Parties Disclosure Of Outstanding Balances Transactions With Related Parties Explantory Disclosure of outstanding balances transactions with related parties. 2024-09-20 [Member] Performance Rights Grant Date One [Member] Schedule of Performance Rights Granted Under OIP Disclosure Of Performance Rights Granted Under OIP [Text Block] The detailed information of performance rights granted under oip. 2024-09-21 [Member] Performance Rights Grant Date Two [Member] 2024-09-25 [Member] Performance Rights Grant Date Three [Member] No. of right Performance Rights Granted Equity Instruments Outstanding, Number of Rights in Share-Based Payment Arrangement Number of performance rights granted equity instruments outstanding, number of rights in share-based payment arrangement. Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Maximum [Member] Schedule of Loss Allowance Disclosure of allowance for credit losses [text block] Schedule of Foreign Currency Risk Disclosure Of Foreign Currency Risk Explantory Disclosure of foreign currency risk. Schedule of Exchange Rates Disclosure of effect of changes in foreign exchange rates [text block] Schedule of Contractual Discounted Cash Flows Disclosure of detailed information about financial instruments [text block] Selling and marketing expenses Selling And Marketing Expenses Abstract Selling Selling expenses, operating Marketing Marketing Expenses The amount of expense relating to the marketing and selling of goods or services. Distribution costs Distribution costs, operating Write down of inventories Inventory write-down Research and development HJF Amount of research and development HJF. MTEC R&D grant MTECRDGrant MTEC R&D grant. EMDG grant EMDGGrant EMDG grant. Other income Other operating income (expense) Depreciation Depreciation expense, operating Employee benefits Employee benefits expense Expected credit losses Expected Credit Losses The amount of expected credit losses. Insurance Insurance expense Investor relations Investor Relations Expenses The amount of investor relation expenses. Legal Legal Expenses The amount of legal expenses. Listing and share registry Listing And Share Registry The amount of listing and share registry. Superannuation Superannuation Expenses The amount of superannuation expenses. Loss from continuing operations before income tax expense Loss Before Income Tax Profit (loss) before tax Tax at the Australian tax rate of 25% (2025: 25%) Tax At The Australian Tax Rate Tax at the Australian tax rate. Tax effect of amounts which are not deductible (taxable) in calculating taxable income: Tax Effect Of Amounts Which Are Not Deductible Taxable In Calculating Taxable Income Abstract R&D tax incentive Tax Effectof Research And Development Tax Incentive The amount that represents the research and development tax incentive. Accounting expenditure subject to R&D tax incentive Tax Effect Of Accounting Expenditure Subjectto Research And Development Tax Incentive The amount representing the accounting expenditure subject to research and development tax incentive. Tax at the Australian tax rate, percentage Tax rate effect of foreign tax rates Schedule Of Revenue And Other Income Abstract Total Revenue from Operating Activities Hyper-immune products revenue Revenue Australian R&D tax incentive refund Australian RDTax Incentive Refund Australian R&D tax incentive refund. General and administrative expenses Selling, general and administrative expense [abstract] Accounting and audit Accounting And Audit The amount of accounting and audit. Bad debts Bad Debts The amount of bad debts expenses. Consulting Professional fees expense Travel and entertainment Travel expense, operating Share-based payment expenses - options Decrease (increase) through tax on share-based payment transactions, equity Share-based payment expenses - performance rights Sharebased Payment Expenses Performance Rights Share-based payment expenses - performance rights. Other Other expenses, by nature Research and development expenses Research And Development Expenses Abstract Consulting Research And Development Consulting Expenses Research and development consulting expenses. Post-employment benefits Key management personnel compensation, post-employment benefits Long-term benefits Key management personnel compensation, other long-term employee benefits, operating Share-based payment expenses to KMP and their related entities Key management personnel compensation, share-based payment Total Key Management Personnel Compensation Key management personnel compensation, operating Cash at Bank and in hand: Cash and cash equivalents [abstract] Cash at bank and in hand Cash Schedule of Trade and Other Receivables [Abstract] Current Trade and other current receivables [abstract] Trade receivables Current trade receivables The group’s share of loss for the period Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share Interests in Other Entities [Table] Total exercise price Proceeds from exercise of options Expire date Expire Date Expire date. Received shares Received shares (in Shares) Received Shares The amount of received shares. Financial assets Financial assets Shares received Shares Received Shares received. Impairment loss (in Dollars) Impairment loss Share of losses Share Of Loss For The Period Share of loss for the period. . investment reduced Impairment Of Investment In Associate The amount of impairment of investment in associate. Unrecognised losses Cumulative unrecognised share of losses of associates Key Management Personnel Compensation Key Management Personnel Compensation Abstract Short-term employee benefits Key management personnel compensation, short-term employee benefits, operating a) Net loss used in the calculation of basic loss per share a) Net loss used in the calculation of diluted loss per share Net Loss for the Year Loss for the Period Loss after income tax expense for the year Profit (loss) b) Weighted average number of ordinary shares outstanding during the period used in the calculation of basic loss per share Weighted average number of ordinary shares used in calculating basic earnings per share b) Weighted average number of ordinary shares outstanding during the period used in the calculation of diluted loss per share Weighted average number of ordinary shares used in calculating diluted earnings per share Schedule Of Cash And Cash Equivalents Abstract Schedule of Subsidiaries [Line Items] Parent Entity: Parent Entity Abstract Place of business/ country of incorporation Country of incorporation of subsidiary Ownership interest held by the group Proportion of ownership interest in subsidiary Schedule Of Losses Were Recognised In Profit Or Loss Abstract Financial Assets and Financial Liabilities - Schedule of Losses Were Recognised in Profit or Loss (Details) [Table] Categories of financial assets [axis] Financial Asset [Member] Financial Asset Member Schedule of Losses Were Recognised in Profit or Loss [Line Items] Total Current Assets Other current assets Other current assets Schedule of Trade and Other Payables [Abstract] Non-current Employee benefit obligations Non-current provisions for employee benefits Leave obligations [Member] Performance bonus [Member] Interests in Other Entities - Schedule of Financial Information for Associates (Details) [Table] Consolidated Entitie [Axis] Consolidated Entitie Axis Interests in Other Entities - Schedule of Financial Information for Associates (Parentheticals) (Details) [Table] Ordinary shares, Fully paid, shares Options granted Number of shares issued and fully paid Other Reserves - Schedule of Movements in Options or Warrants and Performance Rights (Parentheticals) (Details) [Table] Schedule of Movements in Options or Warrants and Performance Rights [Line Items] Other Reserves Scheduleof Movementsin Optionsor Warrantsand Performance Rights Parentheticals Details Line Items Exercise of unlisted options (in Dollars per share) Exercise Of Unlisted Option Price Per Share Exercise of unlisted options Corporate [Member] Corporates Member Share-based payments expense for options previously issued (in Dollars) Sharebased Payments Expense For Options Previously Issued Value Share-based payments expense for options previously issued Issue at US$1.8939 pursuant to At the Market facility (2025-07-17) (in shares) Issue of Shares Market Facility Five Issue of shares market facility five. United States [Member] UNITED STATES Schedule of Segment Information for the Reportable Segments [Line Items] Liabilities Liabilities [abstract] Segment liabilities Segment Liabilities Represents the information of segment liabilities. Disclosure of geographical areas [abstract] Disclosure of geographical areas [table] Geographical areas [axis] Customer B [Member] Customer BMember Represents the information related to customer. Customer C [Member] Customer CMember Represents the information related to customer. Customer D [Member] Customer DMember Represents the information related to customer. Depreciation expense Adjustments for depreciation and amortisation expense Expected credit losses Adjustments For Expected Credit Losses Adjustments for expected credit losses. Finance costs Adjustments for finance costs Finance income Adjustments for finance income Leave provision expense Leave Provision Expense The amount of leave provision expense. Add (increase) / decrease in other operating assets Adjustments for decrease (increase) in other operating receivables Add decrease in financial assets Adjustments for decrease (increase) in financial assets held for trading Add (decrease) / increase in trade and other payables Adjustments for increase (decrease) in trade and other payables Add (decrease) / increase in other operating liabilities Adjustments for increase (decrease) in other operating payables Less: Transaction costs arising on share issues (in shares) Business Acquisition Cost Of Transaction Cost To Issued At Shares Business acquisition cost of transaction cost to issued shares. Less: Transaction costs arising on share issues Business Acquisition Cost Of Transaction Cost The cash outflow for share issue by cost. Schedule Of Other Reserves Abstract Other Reserves - Schedule of Other Reserves (Details) [Table] Other comprehensive income Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans Options and warrants exercised Options And Warrants Exercised Options and warrants exercised. Options issued in the period (net of adjustments) Unlisted Options Vested Amount of unlisted options vested. Options and warrants issued/expensed (net of adjustments) Increase (decrease) through exercise of warrants, equity Lapse of unexercised options Option And Warrants Forfeited After the expiration date, the warrant has expired, and the holder can no longer use it. Under an American-style stock warrant, the holder can exercise his right to buy or sell the shares at any time before the warrant expires. Performance rights issued/expensed Performance Rights Issuedexpensedin Dollars The amount of performance rights issued/expensed . Other Reserves - Schedule of Movements in Options or Warrants and Performance Rights (Details) [Table] Exercise of unlisted options at $0.12 (2024-03-12) (in Dollars) Exercise Of Unlisted Options Value Exercise of unlisted options Performance rights issued in the year Performance Rights Issued Performance rights issued. Performance rights issued in the year (in Dollars) Performance Rights Issueds Performance rights issued. Unlisted Options Issued/Expensed Unlisted Options Issued Expensed Unlisted Options Issued/Expensed. Unlisted Options Issued/Expensed (in Dollars) Unlisted Options Issued Expired Unlisted Options Issued/Expensed. Options issued in the year Options Issued In The Periodnet Of Adjustments Number of shares options issued in the period. Schedule of Information on Geographical Regions [Line Items] Disclosure of major customers [abstract] Disclosure of major customers [table] Major customers [axis] Schedule of Major Customers [Line Items] Total revenue for major customers Revenue Form Contract With Customer Revenue for major customers. Schedule of Reconciliation of Cash Flow From Operations with Loss After Income Tax [Abstract] Share-Based Payments [Line Items] Disclosure of terms and conditions of share-based payment arrangement [line items] Schedule of Total Expenses Arising from Share-Based Payment Transactions [Line Items] Share based payment expense Expense from share-based payment transactions with parties other than employees ConsolidatedEntitieDomain [Domain] Components of equity [domain] Share of loss for the year - 23.6% (2025: 23.6%) Share of loss for period Share of loss for the period. Impairment of investment in associate Impairment of investment in associates Impairment of investment in associate. Ordinary shares, Fully paid, value Issued Capital And Fully Paid Ordinary shares fully paid value. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-11) (in shares) Issue Of Shares On The Exercise Of Performance Rights Three Issue of shares on the exercise of performance rights three. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-15) (in shares) Issue Of Shares On The Exercise Of Performance Rights Four Issue of shares on the exercise of performance rights four. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-16) (in shares) Issue Of Shares On The Exercise Of Performance Rights Five Issue of shares on the exercise of performance rights five. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-11) Issue Of Value On The Exercise Of Performance Rights Three Issue of value on the exercise of performance rights three. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-15) Issue Of Value On The Exercise Of Performance Rights Four Issue of value on the exercise of performance rights four. Issue of shares on the exercise of performance rights at $0.0 per share (2025-12-16) Issue Of Value On The Exercise Of Performance Rights Five Issue of value on the exercise of performance rights five. Shares cancelled pursuant to the buy-back of unmarketable parcels (2026-06-29) (in shares) Shares Cancelled Pursuant To The Buyback Of Unmarketable Parcels Number of shares cancelled pursuant to the buy-back of unmarketable parcels. Shares cancelled pursuant to the buy-back of unmarketable parcels (2026-06-29) Value Cancelled Pursuant To The Buyback Of Unmarketable Parcels Amount of shares cancelled pursuant to the buy-back of unmarketable parcels. Lapse of unexercised options (in Dollars) Lapse Of Unexercise Options Lapse of unexercised options. Major customers [domain] Customer A [Member] Customer AMember Represents the information related to customer. Bonus price per share Bonus price per share on performance rights. Conversion rate price per share Number of conversion rate price per share. 2024-11-18 [Member] Grants Date Three [Member] 2023-11-21 [Member] Grants Date Four [Member] Principal elements of lease payments Payments of lease liabilities, classified as financing activities Interest and other costs of finance paid Interest paid, classified as financing activities Summary of Material Accounting Policies Disclosure Of Summary Of Significant Accounting Policies Explanatory The entire disclosure for significant accounting policies applied by the entity. Critical Accounting Estimates and Judgments Disclosure of accounting judgements and estimates [text block] Revenue and other income Disclosure of revenue [text block] Contributed equity Description Of Accounting Policy For Equity Policy Text Block Represents the information of description of accounting policy for equity policy. Loss per share Description of accounting policy for earnings per share [text block] Rounding of amounts Description Of Accounting Policy For Rounding Of Amounts Policy Text Block The description of the entity rounding of amounts. Goods and services tax (GST) Description Of Accounting Policy For Goods And Services Tax Explanatory Represents the information of description of accounting policy for goods and services tax explanatory. Expiry date Share Based Compensation Arrangement By Share Based Payment Award Award Grant Date An expiration date is the last day that a consumable product such as food or medicine will be at its best quality, according to the manufacturer. Exercise price (in Dollars per share) Exercise Price Options Granted Under OIP Exercise price share options granted under OIP. No. of options Number of other equity instruments outstanding in share-based payment arrangement Share price at grant date (in Dollars per share) Weighted average share price Expected volatility Expected volatility, share options granted Options issued under OIP [Member] Share options [member] Performance rights issued under OIP [Member] Performance Rights OIPMember Schedule Of Loss Allowance Abstract Financial Risk Management Objectivesand Policies Schedule of Loss Allowance [Table] Past due status [axis] Past due status [domain] 1-30 [Member] Later than one month and not later than two months [member] Reserves Reserve of share-based payments Accumulated losses Accumulated other comprehensive income Total comprehensive loss Other comprehensive income, net of tax, cash flow hedges Current Assets Current assets [abstract] Address Type [Domain] Business Contact Business Contact [Member] Document Information [Line Items] Entity Central Index Key Entity Central Index Key Document Type Document Type Document Registration Statement Document Registration Statement Document Annual Report Document Annual Report Current Fiscal Year End Date Current Fiscal Year End Date Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Country Entity Address, Country Contact Personnel Name Contact Personnel Name City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Shell Company Entity Shell Company Amendment Flag Amendment Flag Document Fiscal Period Focus Document Fiscal Period Focus Cash Flows Related to Operating Activities Cash flows from (used in) operating activities [abstract] Options issued/expensed Options issued and expensed Amount of options issued/expensed. Payments for share buy-back Payments for Share Buy-Back Amount of payment for share buy - back. Shares cancelled pursuant to the buy-back of unmarketable parcel Amount of shares cancelled pursuant to the buy-back of unmarketable parcel. Right-of-use assets Paul Brennan [Member] 2025-11-11 [Member] Grant Date Ten [Member] 2025-11-11 [Member] Grants Date One [Member] 2024-11-18 [Member] Grants Date Two [Member] Parent entity financial information Condensed Financial Statements [Text Block] Auditors’ Remuneration Disclosure of auditors' remuneration [text block] Principles of consolidation and equity accounting Description Of Accounting Policy For Principles Of Consolidation Explanatory Policy Text Block Represents the information of disclosure of reconciliation of cash flow from operations with loss after income tax explanatory. Income and revenue recognition Description of accounting policy for recognition of revenue [text block] Grants from government and non-government sources Description of accounting policy for government grants [text block] Income tax Description of accounting policy for income tax [text block] Impairment of assets Description of accounting policy for impairment of non-financial assets [text block] Timing of transfer of goods or services [domain] EMDG grant consulting services [Member] EMDGMember Schedule of All Other Fees [Line Items] EMDG grant consulting services Auditor's remuneration for other services Schedule Of Consolidated Entity Disclosure Statement Abstract Schedule of Consolidated Entity Disclosure Statement [Line Items] Type of entity Legal form of entity Trustee, partner, or participant in joint venture Description Of Trustee Partner Or Participant In Joint Venture The description of trustee, partner, or participant in joint venture. % of share capital held Percentage Of Share Capital Held Percentage of share capital held. Schedule of Key Management Personnel Compensation Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block] Average exercise price per share option, Vested and exercisable Weighted average exercise price of share options exercisable in share-based payment arrangement Number of options, Vested and exercisable Number of share options exercisable in share-based payment arrangement Disclosure of classes of share capital [table] 2020-10-29 [Member] Grant Date Three Member 2020-07-24 (warrants) [Member] Grant Date Four Member 2021-10-26 [Member] Grant Date Five Member 2022-06-27 [Member] Grant Date Six Member 2023-11-21 [Member] Grant Date Seven Member 2024-11-18 [Member] Grant Date Eight Member 2024-11-18 [Member] Grant Date Nine Member Schedule Of Options Granted Under Oip Abstract Dividend yield Expected dividend as percentage, share options granted Risk- free interest rate Risk free interest rate, share options granted Schedule Of Information About Other Related Party Transactions Abstract Related Party Transactions - Schedule of Information About Other Related Party Transactions (Details) [Table] Purchases of various goods and services from entities controlled by key management personnel [Member] Purchases Of Various Goods And Services From Entities Controlled By Key Management Personnel Member Schedule Of Outstanding Balances Transactions With Related Parties Abstract Related Party Transactions - Schedule of Outstanding Balances Transactions with Related Parties (Details) [Table] Key management personnel of entity or parent [member] Trade receivables Trade and other receivables Trade payables Trade payables Total exposure Intangible exploration and evaluation assets USD/AUD exchange rate – change by 3.6% (2025: 4.6%) Net foreign exchange loss Schedule of Audit Service [Abstract] Audit and review of financial statements Auditor's remuneration for audit services, operating Total Auditor's remuneration, operating Schedule Of All Other Fees Abstract Auditors' Remuneration - Schedule of All Other Fees (Details) [Table] Timing of transfer of goods or services [axis] Auditors' Remuneration - Schedule of Consolidated Entity Disclosure Statement (Details) [Table] Immuron Canada Ltd [Member] Immuron Canada Ltd Member Anadis ESP Pty Ltd [Member] Anadis ESPPty Ltd Member Credit losses amount Credt Losses Amount The amount of credit losses amount. Expected credit losses assessment Expected Credit Losses Assessment Represent the amount of expected credit losses assessment. Repurchased and cancelled shares Number of shares repurchased and cancelled on ordinary shares. Number of options, Exercised during the year Number of share options exercised in share-based payment arrangement Average exercise price per share option, Forfeited/lapsed during the year Weighted average exercise price of share options forfeited in share-based payment arrangement Number of options,Forfeited/lapsed during the year Number of share options forfeited in share-based payment arrangement Other [Member] Other Member Rental of an office suite from Wattle Laboratories Pty Ltd [Member] Rental Of An Office Suite From Wattle Laboratories Pty Ltd Member Services rendered by Grandlodge Capital Pty Ltd [Member] Services Rendered By Grandlodge Capital Pty Ltd Member Amounts Settled In Cash Or Shares For Goods And Services Abstract Total Purchases of goods, related party transactions Foreign tax jurisdiction(s) of foreign residents Description Of Foreign Tax Jurisdictions Of Foreign Residents The description of the foreign tax jurisdiction(s) of foreign residents. Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management, Strategy, and Governance [Table] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Other comprehensive income for the period Other comprehensive income, before tax Transactions with owners in their capacity as owners Transactions With Owners In Their Capacity As Owners Abstract Shares issued, net of costs Share issue related cost Options/warrants forfeited Options Or Warrants Forfeited Represents the amount of options or warrants forfeited. Receipts from customers Receipts from sales of goods and rendering of services Payments to suppliers and employees Payments to suppliers for goods and services Australian R&D tax incentive refund Income taxes paid (refund), classified as operating activities Grants received from government and non-government sources Income from government grants, operating Net Cash Flows From Financing Activities Cash flows from (used in) financing activities Net Increase/(decrease) in cash and cash equivalents Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Fair value at grant date per option (in Dollars per share) Fair Value At Grant Date Per Option Fair value at grant date per option. Inventories Current inventories Non-Current Assets Non-current assets [abstract] Other current liabilities Other current liabilities Non-Current Liabilities Non-current liabilities [abstract] Other non-current liabilities Other non-current liabilities Statement of changes in equity [table] Issued Capital Issued capital [member] Accumulated Losses Accumulated Losses Member Represents information related to accumulated losses. Statement of changes in equity [line items] Loss per Share Earnings per share [text block] Financial assets and financial liabilities Disclosure of redesignated financial assets and liabilities [text block] Non-financial assets and liabilities Disclosure of offsetting of financial assets and financial liabilities [text block] Finance costs - net Finance income (cost) Share premium Share-based payments reserve on rights Reserve on Share-Based Payments Rights Represents the amount of reserve on share-based payments rights. Schedule of Performance Rights [Abstract] Schedule of Performance Rights [Table] Schedule of Performance Rights [Table] Schedule of Trade and Other Receivables Disclosure of trade and other receivables [text block] Schedule of Losses Were Recognised in Profit or Loss Disclosure of financial assets [text block] Schedule of Other Current Assets Disclosure of other current assets [text block] Schedule of Trade and Other Payables Disclosure of trade and other payables [text block] Schedule of Inventories and Employee Benefit Obligations Disclosure Of Inventories And Employee Benefit Obligations Text Block Disclosure of inventories and employee benefit obligations Schedule of Other Reserves Disclosure Of Detailed Information Other Reserve The disclosure of detailed information about other reserves. Schedule of Movements in Options or Warrants and Performance Rights Disclosure Of Detailed Information Movements In Options And Warrants The disclosure of detailed information about movements in options and warrants. Schedule of Segment Information for the Reportable Segments Disclosure of products and services [text block] Schedule of Major Product Lines and Geographical Regions Disclosure of geographical areas [text block] Auditor [Line Items] Auditor Name Auditor Firm ID Auditor Location Auditor Opinion [Text Block] Schedule of Major Customers Disclosure of major customers [text block] Schedule of Reconciliation of Cash Flow From Operations with Loss After Income Tax Condensed Cash Flow Statement [Table Text Block] Schedule of Listed and Unlisted Options Disclosure of number and weighted average exercise prices of share options [text block] Schedule of Options Granted Under OIP Disclosure Of Options Granted Under OIPText Block The detailed information of options granted under oip Schedule of Total Expenses Arising from Share-Based Payment Transactions Disclosure Of Total Expenses Arising From Share Based Payment Transactions Text Block The detailed information of total expenses arising from share-based payment transactions Schedule of Information About Other Related Party Transactions Disclosure of transactions between related parties [text block] Schedule of Loss Per Share Disclosure of earnings per share [text block] Schedule of Cash and Cash Equivalents Disclosure of cash and cash equivalents [text block] Schedule of Subsidiaries Disclosure of interests in subsidiaries [text block] Schedule of Financial Information for Associates Disclosure of effect of change of investment entity status on financial statements [text block] Schedule of Share Capital Disclosure of share capital, reserves and other equity interest [text block] Schedule of Movements in Ordinary Shares Disclosure Of Ordinary Shares Explanatory Schedule of ordinary shares. Schedule of Share Options Outstanding Disclosure of range of exercise prices of outstanding share options [text block] Schedule of Performance Rights Granted Under OIP [Line Items] Schedule of Performance Rights [Line Items]